|
1
|
Hong CS, Graham NA, Gu W, Camacho
Espindola C, Mah V, Maresh EL, Alavi M, Bagryanova L, Krotee PA,
Gardner BK, et al: MCT1 modulates cancer cell pyruvate export and
growth of tumors that co-express MCT1 and MCT4. Cell Rep.
14:1590–1601. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu R, Shi P, Nie Z, Liang H, Zhou Z, Chen
W, Chen H, Dong C, Yang R, Liu S and Chen C: Mifepristone
suppresses basal triple-negative breast cancer stem cells by
down-regulating KLF5 expression. Theranostics. 6:533–544. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang J, Liu D, Feng Z, Mao J, Zhang C, Lu
Y, Li J, Zhang Q, Li Q and Li L: MicroRNA-138 modulates metastasis
and EMT in breast cancer cells by targeting vimentin. Biomed
Pharmacother. 77:135–141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Telang N: Putative cancer-initiating stem
cells in cell culture models for molecular subtypes of clinical
breast cancer. Oncol Lett. 10:3840–3846. 2015.PubMed/NCBI
|
|
5
|
Zhu A, Li Y, Song W, Xu Y, Yang F, Zhang
W, Yin Y and Guan X: Antiproliferative Effect of Androgen Receptor
Inhibition in Mesenchymal Stem-Like Triple-Negative Breast Cancer.
Cell Physiol Biochem. 38:1003–1014. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schulenburg A, Blatt K, Cerny-Reiterer S,
Sadovnik I, Herrmann H, Marian B, Grunt TW, Zielinski CC and Valent
P: Cancer stem cells in basic science and in translational
oncology: can we translate into clinical application? J Hematol
Oncol. 8:162015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu L, Zhang L, Hu C, Liang S, Fei X, Yan
N, Zhang Y and Zhang F: WNT pathway inhibitor pyrvinium pamoate
inhibits the self-renewal and metastasis of breast cancer stem
cells. Int J Oncol. 48:1175–1186. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu J, Zhang Y, Leung LH, Liu L, Yang F and
Yao X: Efficacy and safety of angiogenesis inhibitors in advanced
gastric cancer: A systematic review and meta-analysis. J Hematol
Oncol. 18:1112016. View Article : Google Scholar
|
|
9
|
Goel G and Sun W: Ramucirumab, another
anti-angiogenic agent for metastatic colorectal cancer in
second-line setting-its impact on clinical practice. J Hematol
Oncol. 8:922015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Trivanović D, Jauković A, Krstić J,
Nikolić S, Okić Djordjević I, Kukolj T, Obradović H, Mojsilović S,
Ilić V, Santibanez JF and Bugarski D: Inflammatory cytokines prime
adipose tissue mesenchymal stem cells to enhance malignancy of
MCF-7 breast cancer cells via transforming growth factor-β1. IUBMB
Life. 68:190–200. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kasimir-Bauer S, Bittner AK, König L,
Reiter K, Keller T, Kimmig R and Hoffmann O: Does primary
neoadjuvant systemic therapy eradicate minimal residual disease?
Analysis of disseminated and circulating tumor cells before and
after therapy. Breast Cancer Res. 18:202016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mori M, Ito F, Shi L, Wang Y, Ishida C,
Hattori Y, Niwa M, Hirayama T, Nagasawa H, Iwase A, et al: Ovarian
endometriosis-associated stromal cells reveal persistently high
affinity for iron. Redox Biol. 6:578–586. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kanwar JR, Kamalapuram SK, Krishnakumar S
and Kanwar RK: Multimodal iron oxide (Fe3O4)-saturated lactoferrin
nanocapsules as nanotheranostics for real-time imaging and breast
cancer therapy of claudin-low, triple-negative
(ER(−)/PR(−)/HER2(−)). Nanomedicine (Lond). 11:249–268. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sharma B, Varney ML, Saxena S, Wu L and
Singh RK: Induction of CXCR2 ligands, stem cell-like phenotype, and
metastasis in chemotherapy-resistant breast cancer cells. Cancer
Lett. 372:192–200. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xie J, Liu J, Liu H, Liang S, Lin M, Gu Y,
Liu T, Wang D, Ge H and Mo SL: The antitumor effect of tanshinone
IIA on anti-proliferation and decreasing VEGF/VEGFR2 expression on
the human non-small cell lung cancer A549 cell line. Acta Pharm Sin
B. 5:554–563. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Botelho MC and Alves H: Endothelial
progenitor cells in breast cancer. Int J Immunother Cancer Res.
2:1–2. 2016.PubMed/NCBI
|
|
17
|
Teng L, Peng S, Guo H, Liang H, Xu Z, Su Y
and Gao L: Conditioned media from human ovarian cancer endothelial
progenitor cells induces ovarian cancer cell migration by
activating epithelial-to-mesenchymal transition. Cancer Gene Ther.
22:518–523. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Amoury M, Kolberg K, Pham AT, Hristodorov
D, Mladenov R, Di Fiore S, Helfrich W, Kiessling F, Fischer R,
Pardo A, et al: Granzyme B-based cytolytic fusion protein targeting
EpCAM specifically kills triple negative breast cancer cells in
vitro and inhibits tumor growth in a subcutaneous mouse tumor
model. Cancer Lett. 372:201–209. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kong L, Guo S, Liu C, Zhao Y, Feng C, Liu
Y, Wang T and Li C: Overexpression of SDF-1 activates the NF-κB
pathway to induce epithelial to mesenchymal transition and cancer
stem cell-like phenotypes of breast cancer cells. Int J Oncol.
48:1085–1094. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Y, Zou T, Wang S, Chen H, Su D, Fu X,
Zhang Q and Kang X: Genistein-induced differentiation of breast
cancer stem/progenitor cells through a paracrine mechanism. Int J
Oncol. 48:1063–1072. 2016.PubMed/NCBI
|
|
21
|
Yin X, Zhang BH, Zheng SS, Gao DM, Qiu SJ,
Wu WZ and Ren ZG: Coexpression of gene Oct4 and Nanog initiates
stem cell characteristics in hepatocellular carcinoma and promotes
epithelial-mesenchymal transition through activation of Stat3/Snail
signaling. J Hematol Oncol. 8:232015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen Y, Cang S, Han L, Liu C, Yang P,
Solangi Z, Lu Q, Liu D and Chiao JW: Establishment of prostate
cancer spheres from a prostate cancer cell line after phenethyl
isothiocyanate treatment and discovery of androgen-dependent
reversible differentiation between sphere and neuroendocrine cells.
Oncotarget. 7:26567–26579. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang R, Chadalavada K, Wilshire J, Kowalik
U, Hovinga KE, Geber A, Fligelman B, Leversha M, Brennan C and
Tabar V: Glioblastoma stem-like cells give rise to tumour
endothelium. Nature. 468:829–833. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu L, Tong Q, Liu S, Cui J, Zhang Q, Sun
W and Yang S: ZEB1 Upregulates VEGF Expression and Stimulates
Angiogenesis in Breast Cancer. PLoS One. 11:e01487742016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
De Francesco EM, Pellegrino M, Santolla
MF, Lappano R, Ricchio E, Abonante S and Maggiolini M: GPER
mediates activation of HIF1α/VEGF signaling by estrogens. Cancer
Res. 74:4053–4064. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jaeger S, Min J, Nigsch F, Camargo M, Hutz
J, Cornett A, Cleaver S, Buckler A and Jenkins JL: Causal Network
Models for Predicting Compound Targets and Driving Pathways in
Cancer. J Biomol Screen. 19:791–802. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lekovic G, Drazin D, Mak AC and Schwartz
MS: Cyberknife radiosurgery and concurrent intrathecal chemotherapy
for leptomeningeal metastases: Case report of prolonged survival of
a HER-2+ breast cancer patient status-post craniospinal
irradiation. Cureus. 8:e4532016.PubMed/NCBI
|
|
28
|
Suyama K, Onishi H, Imaizumi A, Shinkai K,
Umebayashi M, Kubo M, Mizuuchi Y, Oda Y, Tanaka M, Nakamura M and
Katano M: CD24 suppresses malignant phenotype by downregulation of
SHH transcription through STAT1 inhibition in breast cancer cells.
Cancer Lett. 374:44–53. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gangopadhyay S, Nandy A, Hor P and
Mukhopadhyay A: Breast cancer stem cells: A novel therapeutic
target. Clin Breast Cancer. 13:7–15. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Park MT, Oh ET, Song MJ, Kim WJ, Cho YU,
Kim SJ, Han JY, Suh JK, Choi EK, Lim BU, et al: The
radiosensitivity of endothelial cells isolated from human breast
cancer and normal tissue in vitro. Microvasc Res. 84:140–148. 2012.
View Article : Google Scholar : PubMed/NCBI
|
